This study was conducted by Hai Fang and his team from Peking University and published in Human Vaccines & Immunotherapeutics. The study evaluated the cost-effectiveness of using non-immunization program vaccines as an alternative to current vaccination strategies and simulated the economic and health consequences of meningococcal disease using four vaccination strategies based on the 2019 birth cohort. The result showed that using quadrivalent polysaccharide vaccine (MPV-4), bivalent conjugate vaccine (MCV-AC), and quadrivalent conjugate vaccine (MCV-4) could have increased health benefits but at a higher cost. The new strategies would be cost-effective provided lowering vaccine price.
Factors affecting caregivers’ HPV vaccination decisions for adolescent girls: A secondary analysis of a Chinese RCT
This research, led by Prof. Jing Li from Sichuan University, in collaboration with Prof. Dan Wu from Nanjing Medical University, was published in PLOS ONE. Based on a randomized controlled trial conducted in Chengdu, China, the study investigated key factors influencing caregivers’ actions to vaccinate adolescent girls against HPV. The results highlighted the significant role of a novel “pay-it-forward” intervention in doubling HPV vaccine uptake. Other factors, including caregivers’ knowledge, intention to delay vaccination, occupational status, and prior vaccine refusal, were also strongly associated with vaccination behavior. Recommendations to promote universal and equitable access to HPV vaccine through targeted health education, financial support and community engagement.
